Annual Operating Expenses
$855.20 M
+$190.80 M+28.72%
31 December 2023
Summary:
Apellis Pharmaceuticals annual total operating expenses is currently $855.20 million, with the most recent change of +$190.80 million (+28.72%) on 31 December 2023. During the last 3 years, it has risen by +$415.88 million (+94.66%). APLS annual operating expenses is now at all-time high.APLS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$210.55 M
+$4.53 M+2.20%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly total operating expenses is currently $210.55 million, with the most recent change of +$4.53 million (+2.20%) on 30 September 2024. Over the past year, it has dropped by -$14.52 million (-6.45%). APLS quarterly operating expenses is now -6.45% below its all-time high of $225.07 million, reached on 30 September 2023.APLS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.7% | -6.5% |
| 3 y3 years | +94.7% | +57.7% |
| 5 y5 years | +568.5% | +201.0% |
APLS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +94.7% | -6.5% | +57.7% |
| 5 y | 5 years | at high | +568.5% | -6.5% | +201.0% |
| alltime | all time | at high | >+9999.0% | -6.5% | +7790.0% |
Apellis Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $210.55 M(+2.2%) |
| June 2024 | - | $206.03 M(-3.8%) |
| Mar 2024 | - | $214.21 M(+1.5%) |
| Dec 2023 | $855.20 M(+28.7%) | $210.98 M(-6.3%) |
| Sept 2023 | - | $225.07 M(+8.7%) |
| June 2023 | - | $207.03 M(-2.4%) |
| Mar 2023 | - | $212.12 M(+15.4%) |
| Dec 2022 | $664.40 M(+11.2%) | $183.79 M(+5.9%) |
| Sept 2022 | - | $173.61 M(+5.3%) |
| June 2022 | - | $164.86 M(+16.0%) |
| Mar 2022 | - | $142.13 M(-1.7%) |
| Dec 2021 | $597.64 M(+36.0%) | $144.64 M(+8.4%) |
| Sept 2021 | - | $133.50 M(-31.5%) |
| June 2021 | - | $194.91 M(+56.4%) |
| Mar 2021 | - | $124.59 M(+31.4%) |
| Dec 2020 | $439.32 M(+52.5%) | $94.83 M(-27.2%) |
| Sept 2020 | - | $130.20 M(+12.7%) |
| June 2020 | - | $115.51 M(+16.9%) |
| Mar 2020 | - | $98.79 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $288.01 M(+125.1%) | $105.94 M(+51.5%) |
| Sept 2019 | - | $69.95 M(+10.2%) |
| June 2019 | - | $63.48 M(+30.5%) |
| Mar 2019 | - | $48.65 M(+30.8%) |
| Dec 2018 | $127.92 M(+152.0%) | $37.20 M(+3.9%) |
| Sept 2018 | - | $35.80 M(+6.9%) |
| June 2018 | - | $33.49 M(+56.2%) |
| Mar 2018 | - | $21.44 M(+19.1%) |
| Dec 2017 | $50.77 M(+86.1%) | $17.99 M(+55.3%) |
| Sept 2017 | - | $11.59 M(-4.5%) |
| June 2017 | - | $12.13 M(+34.0%) |
| Mar 2017 | - | $9.05 M(+35.5%) |
| Dec 2016 | $27.28 M(+35.8%) | $6.68 M(-7.7%) |
| Sept 2016 | - | $7.23 M(+3.9%) |
| Dec 2015 | $20.09 M(+77.9%) | $6.96 M(+35.0%) |
| Sept 2015 | - | $5.16 M(+76.9%) |
| Dec 2014 | $11.29 M(+180.3%) | $2.92 M(+9.3%) |
| Sept 2014 | - | $2.67 M |
| Dec 2013 | $4.03 M | - |
FAQ
- What is Apellis Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
- What is Apellis Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
What is Apellis Pharmaceuticals annual total operating expenses?
The current annual operating expenses of APLS is $855.20 M
What is the all time high annual operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total operating expenses is $855.20 M
What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, APLS annual total operating expenses has changed by +$190.80 M (+28.72%)
What is Apellis Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of APLS is $210.55 M
What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total operating expenses is $225.07 M
What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, APLS quarterly total operating expenses has changed by -$14.52 M (-6.45%)